⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
globenewswire.com
NVO
The $59B Quiet Shift Reshaping How Patients Access Care
prnewswire.com
NVO
DNA
HIMS
MNKD
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
globenewswire.com
NVO
PFE
LLY
HIMS
The Next Generation of the GLP-1 Revolution Is Already Underway
globenewswire.com
NVO
PFE
LLY
AMGN
Cellular Intelligence, an AI-native TechBio, Enters Agreement with Novo Nordisk to Advance Clinical-Stage Parkinson's Cell Therapy USA - English Danmark - Dansk Danmark - English
prnewswire.com
NVO
AMD
Insulin Aspart Market Shifts Toward Access and Biosimilar Competition as Rapid-Acting Insulin Remains Essential for Mealtime Glucose Control
accessnewswire.com
NVO
SNY
VTRS
Biotech’s Next Wave May Already be in Motion
globenewswire.com
NTHI
LLY
NVO
REGN
As AI Rewrites Drug Development, the Industry Gathers in Philadelphia to Work Out the Rules
prnewswire.com
PFE
LLY
NVO
AMGN
GOOG
Novo Nordisk's adjusted operating profit reached DKK 32,858 million in Q1 2026
globenewswire.com
NVO
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP